ACHN
Achillion Pharmaceuticals, Inc.
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
130 hedge funds and large institutions have $415M invested in Achillion Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 40 increasing their positions, 42 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
130
Holders Change
-10
Holders Change %
-7.14%
% of All Funds
3.24%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
16
Increased
40
Reduced
42
Closed
19
Calls
$4.31M
Puts
$821K
Net Calls
+$3.49M
Net Calls Change
-$1.51M
Top Buyers
| 1 |
BlackRock
New York
|
+$41.5M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$3.63M |
| 3 |
Millennium Management
New York
|
+$3.32M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.72M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$2.53M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$3.38M |
| 2 |
Goldman Sachs
New York
|
-$3.06M |
| 3 |
HI
HBK Investments
Dallas,
Texas
|
-$2.27M |
| 4 |
Morgan Stanley
New York
|
-$2M |
| 5 |
Citigroup
New York
|
-$1.94M |
